The Association between Progression of Atherosclerosis and the Methylated Amino Acids Asymmetric Dimethylarginine and Trimethyllysine

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Løland, Kjetil H ^a   Bleie, Øyvind ^b   Borgeraas, Heidi ^c   Strand, Elin ^a   Ueland, Per M ^a   Svardal, Asbjørn ^a   Nordrehaug, Jan E ^a,b   Nygård, Ottar ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c VESTFOLD HOSPITAL TRUST   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYANOCOBALAMIN PLUS FOLIC ACID; N(G),N(G) DIMETHYLARGININE; PLACEBO; PYRIDOXINE; TRIMETHYLLYSINE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

ADENOSINE; AGED; ARGININE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; ETHIONINE; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; LYSINE; MALE; METHYLATION; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 84878434944     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064774     Document Type: Article

References (36)

1. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, et al. (2008) Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography: A Randomized Controlled Trial. JAMA 300: 795-804.
2. Ebbing M, Bønaa KH, Arnesen E, Ueland PM, Nordrehaug JE, et al. (2010) Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med 268: 367-382.
3. Celik T, Iyisoy A, Yuksel UC, Isik E, (2008) Homocysteine-lowering vitamins and cardiovascular mortality: Are they really effective? Int J Cardiol 128: 432-433.
4. Ebbing M, Bønaa K, Nygård O, Arnesen E, Ueland PM, et al. (2009) Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302: 2119-2126.
5. Løland KH, Bleie Ø, Blix AJ, Strand E, Ueland PM, et al. (2010) Effect of Homocysteine-Lowering B Vitamin Treatment on Angiographic Progression of Coronary Artery Disease: A Western Norway B Vitamin Intervention Trial (WENBIT) Substudy. Am J Cardiol 105: 1577-1584.
6. Handy DE, Castro R, Loscalzo J, (2011) Epigenetic Modifications. Circulation 123: 2145-2156.
7. Charles M, Johnson I, Belshaw N, (2012) Supra-physiological folic acid concentrations induce aberrant DNA methylation in normal human cells in vitro. EPIGENETICS 7: 689-694.
8. Jung AY, Smulders Y, Verhoef P, Kok FJ, Blom H, et al. (2011) No Effect of Folic Acid Supplementation on Global DNA Methylation in Men and Women with Moderately Elevated Homocysteine. PLoS ONE 6: e24976.
9. Loscalzo J, (2006) Homocysteine Trials- Clear Outcomes for Complex Reasons. N Engl J Med 354: 1629-1632.
10. Cheung P, Lau P, (2005) Epigenetic Regulation by Histone Methylation and Histone Variants. Mol Endocrinol 19: 563-573.
11. Cooke JP, (2004) Asymmetrical Dimethylarginine. Circulation 109: 1813-1818.
12. Valkonen V-P, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, et al. (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358: 2127-2128.
13. Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, et al. (2005) Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease. Circ Res 97: e53-e59.
14. Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, et al. (2009) Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community. Circulation 119: 1592-1600.
15. Bremer J (1983) Carnitine- Metabolism and Functions. Physiol Rev 63.
16. Strijbis K, Vaz FM, Distel B, (2010) Enzymology of the carnitine biosynthesis pathway. IUBMB Life 62: 357-362.
17. Austen W, Edwards J, Frye R, Gensini G, Gott V, et al. (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51: 5-40.
18. Azen SP, Mack WJ, Cashin-Hemphill L, LaBree L, Shircore AM, et al. (1996) Progression of Coronary Artery Disease Predicts Clinical Coronary Events: Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study. Circulation 93: 34-41.
19. Mack WJ, Xiang M, Selzer RH, Hodis HN, (2000) Serial quantitative coronary angiography and coronary events. Am Heart J 139: 993-999.
20. Bleie O, Refsum H, Ueland PM, Vollset SE, Guttormsen AB, et al. (2004) Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention. Am J Clin Nutr 80: 641-648.
21. Bjørndal B, Burri L, Wergedahl H, Svardal A, Bohov P, et al. (2012) Dietary supplementation of herring roe and milt enhances hepatic fatty acid catabolism in female mice transgenic for hTNFα. European Journal of Nutrition 51: 741-753.
22. Levey AS, Greene T, Kusek JW, Beck GL, MDRD Study Group (2000) A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 11.
23. Rothwell PM, (2000) Analysis of agreement between measurements of continuous variables: general principles and lessons from studies of imaging of carotid stenosis. J Neurol 247: 825-834.
24. Geraci M, Bottai M, (2007) Quantile regression for longitudinal data using the asymmetric Laplace distribution. Biostatistics 8: 140-154.
25. Geraci M (2012) lqmm: Linear Quantile Mixed Models. R package version 1.01 ed.
26. Baccarelli A, Ghosh S (2012) Environmental exposures, epigenetics and cardiovascular disease. Curr Opin Clin Nutr Metab Care 15: 323-329 310.1097/MCO.1090b1013e328354bf328355c.
27. Shirodkar AV, Marsden PA (2011) Epigenetics in cardiovascular disease. Curr Opin Cardiol 26: 209-215 210.1097/HCO.1090b1013e328345986e.
28. Zaspel B, Sheridan K, Henderson L, (1980) Transport and metabolism of carnitine precursors in various organs of the rat. Biochim Biophys Acta 631: 192-202.
29. Brown BG, (2007) A direct comparison of intravascular ultrasound and quantitative coronary arteriography: implications for measures of atherosclerosis as clinical surrogates. Circulation 115: 1824-1826.
30. Waters D, Craven T, Lespérance J, (1993) Prognostic significance of progression of coronary atherosclerosis. Circulation 87: 1067-1075.
31. Berry C, L'Allier PL, Gregoire J, Lesperance J, Levesque S, et al. (2007) Comparison of Intravascular Ultrasound and Quantitative Coronary Angiography for the Assessment of Coronary Artery Disease Progression. Circulation 115: 1851-1857.
32. Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, Grines CL, Block E, et al. (2005) Coronary Stent Restenosis in Patients Treated With Cilostazol. Circulation 112: 2826-2832.
33. Rodriguez-Granillo GA, Vos J, Bruining N, Garcia-Garcia HM, de Winter S, et al. (2007) Long-Term Effect of Perindopril on Coronary Atherosclerosis Progression (from the PERindopril's Prospective Effect on Coronary aTherosclerosis by Angiography and IntraVascular Ultrasound Evaluation [PERSPECTIVE] Study). Am J Cardiol 100: 159-163.
34. Rehkopf DH (2012) Commentary: Quantile Regression for Hypothesis Testing and Hypothesis Screening at the Dawn of Big Data. Epidemiology 23: 665-667 610.1097/EDE.1090b1013e318261f318267be.
35. Teerlink T, (2005) ADMA metabolism and clearance. Vasc Med 10: S73-S81.
36. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, et al. (1999) Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies. Am J Epidemiol 150: 341-353.